熱門資訊> 正文
InterCure H1收入NIS125.733万英镑，同比下降208.614万英镑，调整后EBITDA NIS20.829万英镑，同比下降29.669万英镑
2024-08-30 16:13
- Revenues for the first half of 2024 were affected by damages caused by the terrorist attack on October 7, 2023, and the war in Gaza.
- InterCure is entitled to full compensation from the Israeli authorities for all direct and indirect damages caused to its Southern Facility located at Kibbutz Nir Oz. To date, InterCure has already received tens of millions of NIS as partial advance payments from the Israeli authorities.
- Announced Expansion of its strategic partnership with Cookies™ to Germany and expects to launch first Cookies products in Germany in the fourth quarter of 2024.
- Restoring the Southern Facility continues in accordance with receiving advance payments from the Israeli authorities.
- Expects double digit growth throughout the second half of 2024 (compared to first half of 2024) due to expected launches in German and UK markets.
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
